Umb Bank, N.A. Astrazeneca PLC Transaction History
Umb Bank, N.A.
- $5.99 Billion
- Q2 2024
A detailed history of Umb Bank, N.A. transactions in Astrazeneca PLC stock. As of the latest transaction made, Umb Bank, N.A. holds 12,458 shares of AZN stock, worth $966,989. This represents 0.02% of its overall portfolio holdings.
Number of Shares
12,458
Previous 11,696
6.52%
Holding current value
$966,989
Previous $792,000
22.6%
% of portfolio
0.02%
Previous 0.01%
Shares
9 transactions
Others Institutions Holding AZN
# of Institutions
1,333Shares Held
490MCall Options Held
4.99MPut Options Held
3.19M-
Price T Rowe Associates Inc Baltimore, MD64.9MShares$5.04 Billion0.61% of portfolio
-
Primecap Management CO Pasadena, CA42.6MShares$3.31 Billion2.44% of portfolio
-
Wellington Management Group LLP Boston, MA40.6MShares$3.15 Billion0.58% of portfolio
-
Capital International Investors Los Angeles, CA36.7MShares$2.85 Billion0.6% of portfolio
-
Franklin Resources Inc San Mateo, CA17.6MShares$1.37 Billion0.44% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $241B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...